NorthernBio
NorthernBio is a premier preclinical CRO providing in vivo modeling, safety, and efficacy testing across five core therapeutic areas: Neuroscience (focusing on neurodegenerative and psychiatric CNS disorders with targeted central dosing for gene therapies), Ophthalmology (utilizing precise ocular routes like subretinal and intravitreal administrations), Cardiovascular (evaluating devices and therapeutics via myocardial infarction and heart failure models), Metabolic Diseases (including Type 1 and Type 2 diabetes modeling), and Rare/Orphan Diseases requiring highly tailored protocol designs.
